Physician

Gregory Mark Singer, M.D.

According to 2025 Medicare claims, Gregory Singer, M.D. (NPI: 1114010865) practices cardiology in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is CARDIOLOGY CONSULTANT OF ROCHESTER, PLLC (NPI: 1851695431; TIN: 274347283) and primary practice location at 14626-4209.

Singer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 303 traditional Medicare patients, billed 2,258 HCPCS/CPT codes, and received $141,051 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 12,689 prescription claims across 1,542 beneficiaries totaling $2,454,769 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 4 records totaling $94. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $925,970 to $2,454,769. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	589	3,322	$227,313
2016	599	3,474	$251,363
2017	620	3,739	$245,408
2018	597	4,194	$301,653
2019	586	4,259	$315,644
2020	519	3,445	$255,958
2021	438	3,280	$270,385
2022	381	2,762	$212,967
2023	336	2,639	$148,276
2024	303	2,258	$141,051

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,238	11,679	$925,970
2016	1,341	12,948	$1,311,913
2017	1,382	13,690	$1,497,979
2018	1,441	14,031	$1,607,252
2019	1,548	15,153	$1,846,326
2020	1,532	13,325	$2,144,103
2021	1,543	12,126	$2,289,087
2022	1,511	12,209	$2,353,328
2023	1,527	12,543	$2,438,273
2024	1,542	12,689	$2,454,769

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	174	178	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	234	381	$85
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	50	109	$15
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	184	259	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	254	388	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,131	71,633	$1,321,219
Xarelto	Rivaroxaban	251	17,825	$316,235
Entresto	Sacubitril/Valsartan	214	13,174	$242,655
Multaq	Dronedarone Hcl	140	7,080	$174,119
Jardiance	Empagliflozin	78	3,930	$73,244

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$94	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gregory Mark Singer, M.D.?

Tedicare shows public-source Medicare data for Gregory Mark Singer, M.D. (NPI 1114010865), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory Mark Singer, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gregory Mark Singer, M.D.?

Gregory Mark Singer, M.D. is linked to CARDIOLOGY CONSULTANT OF ROCHESTER, PLLC (billing NPI 1851695431) in the available physician profile data.

Does Gregory Mark Singer, M.D. have Open Payments data?

Gregory Mark Singer, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.